![](https://endpts.com/wp-content/uploads/2022/06/David-Hung.jpg)
David Hung, Nuvation Bio CEO
Nuvation inks all-stock deal for US-China oncology biotech AnHeart
Nuvation Bio plans to buy AnHeart Therapeutics in an all-stock deal, the cancer drug developers said Monday morning, in a move …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.